Cataract and Refractive Surgery

Cataract and Refractive Surgery News

  • AAO 2018 Drug Pipeline for Macular Degeneration in Focus at AAO Updates from phase 3 trials of VEGF inhibitors for neovascular age-related macular degeneration, and a novel genetic treatment, will be highlighted at the American Academy of Ophthalmology meeting.
  • Alert FDA OKs Fluocinolone Intravitreal Implant (Yutiq) for Uveitis In clinical trials, Yutiq significantly reduced recurrence rates at 6 and 12 months following treatment compared with sham treatment in patients with chronic, noninfectious posterior segment uveitis.

Cataract and Refractive Surgery Perspective



read here